Upon completion of this session, you should be able to:
1. Use the concepts of pre-test probability, and positive and negative predictive values as they apply to testing for fetal aneuploidy.
2. Outline advantages and disadvantages of various approaches to first-trimester and second-trimester screening, as well as invasive diagnostic testing for Down syndrome.
3. Summarize the current recommendations for cystic fibrosis testing and the importance of “residual risk.”
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View AAFP staff list (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Susanna Magee, MD, MPH, Director, Maternal Child Health Program, Memorial Hospital of RI/Alpert Medical School of Brown University
- 0.75 AAFP prescribed